Skip to content

Dyskeratosis Congenita Autosomal Recessive 3 C3151442

Published: July 22, 2026Updated: August 27, 2026

A rare genetic disorder affecting bone marrow function and causing skin changes. Leads to anemia, infections, and increased cancer risk. Management focuses on treating bone marrow failure and regular cancer screening.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Hematopoietic Stem Cell Transplantation

Bone marrow or stem cell transplantation for treatment of bone marrow failure and aplastic anemia associated with the telomere biology disorder.

surgical
3

Cancer Surveillance Program

Regular screening for malignancies including head and neck cancers, anogenital cancers, and skin cancers with frequent examinations and imaging.

monitoring

Additional treatment options

Bone Marrow and Hematologic Monitoring

Frequent blood count monitoring, bone marrow evaluation, and assessment for progression of bone marrow failure or myelodysplastic syndrome.

monitoring

Androgen Therapy

Androgen therapy such as oxymetholone may be used to support blood cell production in selected patients with bone marrow failure.

medication

Supportive Care for Dermatologic Manifestations

Management of skin pigmentation changes, nail dystrophy, and oral leukoplakia with dermatologic care and supportive treatments.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dyskeratosis Congenita Autosomal Recessive 3 C3151442?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Dyskeratosis Congenita Autosomal Recessive 3 C3151442. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy